To investigate the effects of SPRY2 on FGFR1 endocytosis and degradation, we used the two human GBM cell lines U251 and SF126, with low and high endogenous SPRY2 protein content, as described before [43,52]. This evidence concerns the gene FGFR1 and glioblastoma.